Trimethadione

From Wikipedia, the free encyclopedia
Jump to: navigation, search
This article is about the drug Tridione. For the content management software Tridion, see SDL plc.
Trimethadione
Trimethadione.svg
Clinical data
Trade names Tridione
AHFS/Drugs.com Micromedex Detailed Consumer Information
Pregnancy
category
  • X
Routes of
administration
By mouth
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability High
Metabolism Demethylated to dimethadione
Biological half-life 12–24 hours (trimethadione)
6–13 days (dimethadione)
Excretion Renal
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
ECHA InfoCard 100.004.406
Chemical and physical data
Formula C6H9NO3
Molar mass 143.141 g/mol
3D model (Jmol)
  (verify)

Trimethadione is an oxazolidinedione anticonvulsant. It is most commonly used to treat epileptic conditions that are resistant to other treatments.

Fetal trimethadione syndrome[edit]

If administered during pregnancy, fetal trimethadione syndrome may result causing facial dysmorphism (short upturned nose, slanted eyebrows), cardiac defects, intrauterine growth restriction (IUGR), and mental retardation. The fetal loss rate while using trimethadione has been reported to be as high as 87%.[1]

References[edit]

External links[edit]